IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
20 hedge funds and large institutions have $3.27M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holding in Top 10
–
Calls
$2.21M
Puts
–
Top Buyers
1 | +$1.45M | |
2 | +$209K | |
3 | +$207K | |
4 |
LA
Linden Advisors
New York
|
+$169K |
5 |
SC
Sculptor Capital
New York
|
+$160K |
Top Sellers
No sellers this quarter